Townsend Asset Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Townsend Asset Management's IBB Position: Q2 2026 in Review
Townsend Asset Management held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 52 shares worth $9.86K. The position accounts for ﹤0.01% of the portfolio, ranked #175.
Townsend Asset Management first reported a position in IBB in Q4 2019 and has held it in 27 quarters since. The position peaked at $17K in Q3 2021. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Townsend Asset Management held 52 shares of iShares Biotechnology ETF worth $9.86K as of Q2 2026.
- Townsend Asset Management left its iShares Biotechnology ETF share count unchanged in Q2 2026.
- iShares Biotechnology ETF made up ﹤0.01% of Townsend Asset Management's portfolio in Q2 2026, its #175 holding.
- Townsend Asset Management first reported a position in iShares Biotechnology ETF in Q4 2019 and has held it in 27 quarters since.
- Townsend Asset Management's iShares Biotechnology ETF position peaked at $17K in Q3 2021.
- 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Townsend Asset Management's 13F filing for Q2 2026, filed 24 Jul 2026.